Drug Profile
RKS 1443
Latest Information Update: 14 Sep 1998
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 14 Sep 1998 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 18 Sep 1996 New profile
- 18 Sep 1996 Preclinical development for HIV-1 infections in Japan (Unknown route)